PARTNERING DAY
December 3rd, 2018

Fostering Innovation

Boehringer Ingelheim knows what it takes to be innovative and entrepreneurial. From the small factory in 1885 to today’s global pharmaceutical organisation, we know how important it is to nurture and develop emerging science and technology.
Our track record of bringing breakthrough medicines to patients starts with new ideas and new science, and collaborations with external partners play a key role in helping us deliver an innovation-led portfolio. Join us at our partnering day to explore how we can develop the next generation of medicines together.
For more information on our partnering interests please visit: www.boehringer-ingelheim.com/partnering/interests.

Meet our research and partnering team

Research and partnering teams will be available throughtout the day for networking.

Register to attend and apply for a one-to-one meeting

Register to attend the event and, if interested, apply for a one-to-one meeting to discuss potential opportunities for partnering with our team.

Deadline: 1st November

Many thanks to GENFIT for joining BioFIT 2018 as a Bronze Sponsor!

GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diangostics solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology.

Join key BioFIT 2018 sponsors such as PfizerBayerRocheMSDBoehringer IngelheimLFB, GENFIT and VIB to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.

For more information about the sponsorship opportunities, visit the dedicated site page.

The European Genomic Institute for Diabetes (EGID) will host its 5th international symposium: the gut, incretins and diabetes, from December 4th, 2018, Lille.

This biennial event brings an international focus to our work by the joining of the IDEA Summit and the EGID symposium.
The committee and speakers are world leaders in their fields and will present the latest scientific advances in diabetes and related disorders.
This symposium provides an opportunity for young researchers to present their work via poster presentation and to win the “Best Poster Award” of up to 1000 euros.

Conference Programme:

8.30 – 9.15 AM
WELCOME COFFEE & SYMPOSIUM MATERIAL DISTRIBUTION

9.15 – 9.30 AM
INTRODUCTION AND WELCOMING

9.30 – 10.15 AM
INSIGHTS FROM BARIATRIC SURGERY

RACHEL BATTERHAM
Professor of Obesity, Diabetes and Endocrinology – NIHR Research Professor, Head of UCLH Obesity & Bariatric Services, Head of Center for Obesity Research, Department of Medicine, Rayne Building, University College London

10.15 – 11.00 AM
FOOD AND TYPE 2 DIABETES: RESTORING THE INSIDE OF THE SYSTEM

ROY TAYLOR
Professor of Medicine and Metabolism, Magnetic Resonance Centre, Campus for Ageing and Vitality, Newcastle upon Tyne

11.00 – 11.30 AM
EGID POSTER SESSION

11.30 AM – 1.00 PM
BIOFIT PLENARY SESSION: Seed funds crossing borders: How far and how fast is the early-stage investment market in Biotech globalising?

1:00 PM – 2.30 PM
LUNCH

2.30 – 3.15 PM
INCRETINS, DIABETES AND CV DISEASE

NIKOLAUS MARX
Director of the Medical Cardiology Clinic – Cardiology, pneumonology, angiology, internal intensive care Aachen University Hospital

3.15 – 4.00 PM
GUT-BRAIN GLUCOSE SIGNALING IN THE CONTROL OF ENERGY HOMEOSTASIS

GILLES MITHIEUX
Research Director – CNRS Director of U1213, Nutrition, Diabetes and the Brain

4.00 – 4.30 PM
NETWORKING BREAK

4.30 – 5.15 PM
THERAPEUTIC POTENTIAL OF MULTI-INCRETIN THERAPY – FROM MICE TO MEN

AIMO KANNT
Head of Department, General Metabolism & Obesity, Sanofi

5.15 – 5.30 PM
BEST PAPER AWARD

5.30 – 6.00 PM
CONCLUSION & INVITATION TO THE CHEESE AND WINE COCKTAIL

Partners:

BioFIT and the WBC Incubator are pleased to announce that they will be putting together a special edition of WBC Club during BioFIT 2018 in Lille. This session, called «Would-be CEO Networking Lunch», will be held on the second day of BioFIT (5th December).

As talented CEOs are so much sought-after by so many stakeholders of the biotech industry, to both launch and drive new companies to success, this special WBC Club session will bring together representatives of emerging start-ups, technology transfer offices, incubators and investing networks as well as CEOs and would-be CEOs to address this crucial issue.

Since 2010, WBC Incubator has validated close to 100 biotech professionals in Belgium for their ability to match and work with scientific founders and entrepreneurs with the collective aim to build together more exciting business plans, stronger investment propositions and faster business development programmes. In Belgium, biotech CEOs and Would-be CEOs meet regularly to discuss business opportunities during so-called WBC Club events.

The «Would-be CEO Networking Lunch» is organised to present the WBC incubation model to BioFIT participants. Please also note that Would-be CEOs will be identified using the BioFIT partnering platform.

Any bioentrepreneur looking for a project to get involved in is welcome to join BioFIT and particularly this would-be CEOs networking lunch. Any incubator or tech transfer entity looking for an entrepreneur to lead their start-up launch projects is also welcome to join.

In 5 days, it will be too late to enjoy the Early Bird offer!

If you are interested in attending BioFIT on 4th and 5th December 2018 in Lille, France,  enjoy the Early Bird offer before it ends, after this Saturday it will be too late!

Book your booth now!

As an Exhibitor, you will gain high visibility among top leaders in the Life Sciences sector.
Ideally located at the focal point of the event, the Exhibition area enables participants to access key information, expand their network, highlight their skills, services and innovations and enhance their visibility.

6m² fitted booth – € 2,200
(1 partnering pass included)

9m² fitted booth – € 3,300
(1 partnering pass included)

12m² fitted booth – €4,400
(1 partnering pass included)

18m² fitted booth – €6,600
(2 partnering passes included)

 

Many thanks to VIB for joining BioFIT 2018 as a Bronze Sponsor!

 VIB is a life sciences research institute, based in Flanders, Belgium. They perform basic research with a strong focus on translatin​g scientific results into pharmaceutical, agricultural and industrial applications.

Join key BioFIT 2018 sponsors such as Bayer, RocheMSDBoehringer Ingelheim, Pfizer and LFB, to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

 

They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.

For more information about the sponsorship opportunities, visit the dedicated site page.

BioFIT 2018 will host the 4th edition of the “R&D dating for Animal Health and Innovation” business convention, at the French association for the animal healthcare industry (SIMV)’s initiative, on the 4th and 5th of December 2018, in Lille.

Today, public-private and private-private partnerships are thought to be the leverage that is needed for innovation. That is why the SIMV launched the “R&D dating for Animal Health and Innovation”, which strives to initiate high-level exchanges between research departments of the veterinary medicine and diagnostics industry and public research, as well as with biotechnology companies (start-ups).

By enabling face-to-face encounters, the event will enhance the visibility of cutting-edge research in France and in Europe, encourage investments and lead to therapeutic innovation.

About SIMV

While being the organiser of this meeting, the SIMV intends to federate research actors by actively contributing to meet the needs in animal health innovation. In particular, enhanced research is needed to supplement and renew the therapeutic arsenal for the treatment of infectious diseases and therefore research and innovation on this topic should be promoted.

Many thanks to LFB for joining BioFIT 2018 as a Contributing Sponsor!

Since it was formed in 1994, the LFB Group has been developing, manufacturing and marketing biological medicinal products, for diseases that are always serious and often rare. The LFB Group is now one of the leading European players in biopharmaceutical, its products are aimed at health professionals, mainly hospital-based, these are medicinal products derived from living organisms in three major fields of therapy: immunology, haemostasis and intensive care.

The LFB group is a biopharmaceutical company, one of the rare manufacturers in the world with expertise in different bioproduction techniques, offering plasma-derived medicinal products, recombinant medicinal products and advanced therapy treatments such as cell therapies. The LFB Group’s strategy is focused on international growth and an active research and development policy in its fields of therapeutic excellence.

LFB is a public company and the Group is growing in a competitive sector, with medicinal products sold in nearly 60 countries. Over 2000 employees of the LFB Group, both in France and worldwide, are totally committed to meeting the needs of hundreds of thousands of patients. Every year, LFB’s 23 biopharmaceuticals are used to treat hundreds of thousands of patients with serious and often rare diseases.

Join key BioFIT 2018 sponsors such as Bayer, Roche, MSD, Boehringer Ingelheim, Pfizer and VIB, to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
  • Highlight your interest in early-stage innovation
  • Present your ideas and technologies to key innovation players in Life Sciences
  • Enhance your visibility on an international scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

They were the BioFIT 2017 sponsors: Sanofi, Pfizer, Bayer, Genfit, Lilly, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni.

For more information about the sponsorship opportunities, visit the dedicated site page.

#BioFIT2018 preliminary programme is now available

In this brochure, you will find all the information you need about the 7th edition of the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation in the field of Life Sciences.